Netflix, UnitedHealth, Novo Nordisk, Tesla And Trump Media: Why These 5 Stocks Are On Investors' Radars Today

Wall Street experienced a resurgence in risk appetite on Thursday as optimism grew around trade negotiations. President Donald Trump expressed confidence in reaching agreements with both the European Union and China.

On Thursday, the Dow Jones Industrial Average fell 1.3% to close at 39,142.23. The Nasdaq dipped 0.13%, finishing at 16,286.45. Meanwhile, the S&P 500 edged up 0.13%, ending the day at 5,282.70.

These are the top stocks that gained the attention of retail traders and investors throughout the day:

Netflix Inc. NFLX

Netflix shares rose by 1.19% to close at $973.03, reaching an intraday high of $984.70 and a low of $956. The stock’s 52-week range is $542.01 to $1064.50. In the after-hours trading, shares spiked 3.5% to $1,006.79. The streaming giant reported its first-quarter financial results, emphasizing efforts to improve and expand its offerings. The company continues to focus on enhancing its content library and user experience. For the period, revenue came in at $10.54 billion, a spike of 12.5% on a year-over-year basis. Earnings per share were reported at $6.61, beating the estimate of $5.74.

UnitedHealth Group Inc. UNH

UnitedHealth’s stock plummeted by 22.38% to $454.11, with a daily high of $489.79 and a low of $447.10. The 52-week range stands at $438.50 to $630.73. The healthcare giant faced a steep decline after reporting disappointing quarterly results, attributed to rising healthcare costs. CEO Andrew Witty stated that the current cost structure is unsustainable, leading to a downward revision of earnings guidance. UnitedHealth cut fiscal 2025 earnings guidance and expects it to come in the range of $26 to $26.50 from the earlier range of $29.50 to $30 per share.

Novo Nordisk A/S NVO

As the buzz surrounding the impending interest rate cut by the Federal Reserve intensifies, a whirlwind of uncertainty grips the financial markets. What seemed like a foregone conclusion merely days ago has been upended, catapulting the potential for heightened volatility in the trading arena.

Riding the Roller Coaster: Market Expectations Swerve

Just a week ago, all bets were on a modest quarter-point rate reduction at the September FOMC meeting. The CME Group's FedWatch Tool indicated an 85% likelihood of this conservative move earlier this month. However, the scenario has drastically shifted, with a 63% probability now assigned to a bolder 50-basis-point cut.

The catalyst behind this abrupt change? None other than Nick Timiraos.

The Enigmatic "Fed Whisperer": Nick Timiraos

A year ago, a Wall Street Journal article authored by Timiraos caught the attention of market watchers, earning him the moniker of the "Fed Whisperer." His foresight into Federal Reserve policy decisions has been uncanny, with his words often holding prophetic weight.

Decoding Timiraos' Signal: A 25 vs. 50 Basis Points Dilemma

In a recent WSJ piece titled "The Fed’s Rate-Cut Dilemma: Start Big or Small?" Timiraos threw a curveball into the interest rate cut equation. While the consensus had settled on a 25-basis-point reduction, Timiraos' article introduced the possibility of a more substantial 50-point move, plunging the market into disarray.

By ambiguously referencing both options in his writing, Timiraos added fuel to the fire of uncertainty. The article's conclusion, leaning slightly towards the 50-basis-point cut, further stirred the pot.

Guidance in Question: The Fed's Forward Communication Strategy

The Federal Reserve traditionally relies on "forward guidance" to prepare the market for impending policy shifts. Providing a roadmap through official statements or trusted commentators like Timiraos is paramount to prevent shockwaves in the financial realm.

However, the fallout from Timiraos' recent article paints a different picture. Rather than clarity, confusion and market jitters have emerged, challenging the very essence of effective communication from the Fed.

The Aftermath: Lingering Uncertainty and Discontent

Analysts and investors alike are grappling with the aftermath of Timiraos' bombshell. The sudden wave of uncertainty has sparked discussions, with some questioning the Fed's mandate in pleasing Wall Street versus prioritizing transparency and guidance.

As market participants brace themselves for the outcome of the Fed's decision, the echo of Timiraos' enigmatic prose reverberates in the halls of finance, leaving a trail of anticipation and bewilderment.

Unraveling the Drama: Powell, Timiraos, and the Market Turbulence Unraveling the Drama: Powell, Timiraos, and the Market Turbulence

Novo Nordisk shares fell by 7.63% to $58.08, with an intraday high of $59.06 and a low of $57.28. The stock’s 52-week range is $57.28 to $148.15. An analyst from BMO Capital Markets downgraded the stock, citing concerns about its performance in the cardiometabolic space compared to competitors like Eli Lilly.

Trump Media & Technology Group Corp. DJT

Trump Media’s stock surged by 11.65% to $22.04, hitting a high of $22.77 and a low of $19.82. The 52-week range is $11.75 to $56.55. The company saw its shares rise after filing a complaint with the SEC regarding potential market manipulation and unusual trading patterns.

Tesla Inc. TSLA

Tesla’s stock edged down by 0.07% to close at $241.38, with a high of $244.34 and a low of $237.68. The 52-week range is $138.80 to $488.54. Despite a decline in new vehicle registrations in California, Tesla remains a significant player in the electric vehicle market, according to recent data.

Trump Media or Netflix? Find out how they stack up in terms of Momentum and Growth with Benzinga Edge Stock Rankings.

Photo Sutthiphong Chandaeng via Shutterstock

Prepare for the day’s trading with top premarket movers and news by Benzinga.

Read Next:

This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal

Market News and Data brought to you by Benzinga APIs

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

Netflix, UnitedHealth, Novo Nordisk, Tesla And Trump Media: Why These 5 Stocks Are On Investors' Radars Today

Stock Score Locked: Want to See it?

Latest articles

Astera Labs vs. Advanced Micro Devices: What the Revenue Trajectories of These Artificial Intelligence Companies Reveal to Investors.

Nvidia Stock: Buy Right Now or Wait for a Better Opportunity?

New Strong Buy Stocks for July 23rd

Astera Labs vs. Advanced Micro Devices: What the Revenue Trajectories of These Artificial Intelligence Companies Reveal to Investors.

Nvidia Stock: Buy Right Now or Wait for a Better Opportunity?

New Strong Buy Stocks for July 23rd